NeonMind to Present at H.C. Wainwright Bioconnect Conference

VANCOUVER, BC / ACCESSWIRE / January 6, 2022 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company, announced today that Robert Tessarolo, President and Chief …